Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  NuPathe Inc    PATH   US67059M1009

NUPATHE INC (PATH)

3
 SummaryQuotesNewsCalendarCompanyFinancials 
Company
NuPathe Inc. is a biopharmaceutical company focused on the development and commercialization of branded therapeutics for diseases of the central nervous system, including neurological and psychiatric disorders.Its primary product, Zecuity (sumatriptan iontophoretic transdermal) for the acute... 
Sector
Pharmaceuticals
Calendar
08/11Earnings Release
More about the company
Latest news on NUPATHE INC
05/01DJDrug Maker Mylan Sues Law Firm Kirkland & Ellis
2014 Analysis - Replay of energetic deal-making seen for drugmakers in 2014
2014DJU.S. HOT STOCKS : Hot Stocks to Watch
2014 NUPATHE INC : Endo Merger Agreement with NuPathe Terminated
2014 NuPathe Terminates Agreement With Endo and Enters Into Agreement to Be Acquir..
2014 NUPATHE INC : NuPathe Inc. Stockholders Encouraged to Contact Securities Law Fir..
2014 S&P 500 ends flat in wake of Fed minutes
2014DJU.S. HOT STOCKS : Hot Stocks to Watch
More news
Sector news : Pharmaceuticals - NEC
05:42p ASTRAZENECA : Cephalon to pay to resolve Medicaid allegations - U.S
12:56p TEVA PLANS TO RAISE MYLAN BID BY AS : Bloomberg
12:52pDJTeva May Raise Offer for Mylan to Range of $86 to $88 a Share -Bloomberg
More sector news : Pharmaceuticals - NEC


Comments 
Advertisement
Income Statement Evolution
More Financials